Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Genetics of primary progressive multiple sclerosis.
The Alice in Wonderland syndrome: an unusual in acute disseminated encephalomyelitis.
Increasing age at disability milestones among MS patients in the MSBase Registry.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
Secukinumab (AIN457) showed superiority over Enbrel® in clearing skin, according to pivotal Novartis Phase III psoriasis results at EADV
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Management of multiple sclerosis: An overview.
Laquinimod CHMP/EMA opinion
The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients.
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Recommendations for the management of multiple sclerosis relapses.
Ibuprofen-induced unilateral optic neuritis.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Substance Name: Riluzole
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning.
Spasticity: pathophysiology, evaluation and management.
Speedy eye movements in multiple sclerosis: Association with performance on visual and nonvisual cognitive tests.
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial.
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
[Neuromyelitis optica in the elderly: An unusual demyelinating disease.]
PLA2G6 mutations and other rare causes of Neurodegeneration with Brain Iron Accumulation.
An evidence-based review of natalizumab therapy in the management of Crohn's disease.
Association of a deficit of arousal with fatigue in multiple sclerosis: Effect of modafinil.
Pages
« first
‹ previous
…
162
163
164
165
166
167
168
169
170
…
next ›
last »